Authors
Latest:
Choosing a Biologic in Psoriasis With Ahmad Amin, MD, FAADAhmad Amin, MD, FAAD, reviews biologic selection in patients with psoriatic disease.
Latest:
Is OX40 Inhibition the Next Game Changer for Atopic Dermatitis?Learn more about the OX40-OX40L pathway and 2 drugs heading toward phase 3 trials.
Latest:
We are Biologic Coordinators of Dermatology (BCoD)Explore how BCs are supported through complex drug approvals and ensuring patients have access to prescribed medications.
Latest:
Nailing Common, Rare, and Scary Pediatric Nail Conditions and SurgeriesJane Bellet, MD, will present 2 sessions full of pearls to ensure tiny fingers and toes are cared for in a timely, heartfelt, and effective treatment regimen.
Latest:
AAD, Janssen, and Kenvue Partner to Mentor Next Generation of DermatologistsDaphne Chan, PhD, MHEcon, discusses the Pathways program, a partnership between the AAD, Janssen, and Kenvue to mentor young, aspiring dermatology providers.
Latest:
Study Reveals Majority of US Adults Distrust Health Care System’s Use of AIA study found that 65.8% of US adults distrust their health care system’s use of AI, highlighting a need for better communication on AI tools.
Latest:
Celebrating Women’s History Month with Mindy Haws, MD, and the LIMITLESS Initiative“It's so exciting to see all these incredible female talents behind me. I want to give back and I want to help them climb on my shoulders and go higher,” Haws said.
Latest:
Current Unmet Needs and Emerging Solutions in Atopic Dermatitis ManagementAlexandra Golant, MD discusses how addressing severe, recalcitrant atopic dermatitis remains the most pressing unmet need, with emerging biologics, oral JAK inhibitors, and combination therapies offering promising new approaches for these challenging cases.
Latest:
Tackling Unmet Needs in Dermatology With RezpegaldesleukinJonathan Zalevsky, PhD, discusses the unmet needs in atopic dermatitis treatment, the potential of Rezpeg, and the importance of novel therapies.
Latest:
Educational and Unmet Needs in GPP ManagementAn expert in dermatology shares his thoughts on the educational and unmet needs in the identification and management of patients with GPP.
Latest:
Closing the Gap in Pediatric Atopic Dermatitis: Experts Push for Steroid-Free AdvancementsDiscover the latest advancements in pediatric atopic dermatitis care, featuring expert insights on innovative treatments and family-centered management strategies.
Latest:
Managing Your Pediatric Dermatology Practice and Life: Insights from Brandie Metz, MD, and Megha Tollefson, MDMetz and Tollefson share insights on efficient practice management, work-life balance, and exciting developments in pediatric dermatology.
Latest:
Clinician and Patient Pearls on Managing Atopic DermatitisJennifer Holman, MD, FAAD, and her patient, Audrey Dean, discuss pearls and key take-aways from their experience managing atopic dermatitis. Jennifer Holman wraps up discussing anticipated therapeutic developments and unmet needs.
Latest:
OX40-Ligand: A Conductor of the Atopic Dermatitis Inflammatory Symphony?Given the complexity of the underlying inflammation in patients with AD, an increased understanding of the OX40L pathway can improve our understanding of AD pathogenesis.
Latest:
Trauma-Induced Melanocyte Implantation Leading to Subcutaneous MelanomaTrauma-induced melanocyte implantation can lead to subcutaneous melanoma, mimicking melanoma of unknown primary but with distinct diagnostic criteria.
Latest:
Orit Markowitz, MD: Cutting Edge Dermatology - Without Cutting the SkinOrit Markowitz, MD, discusses pearls her SDPA fall conference sessions, "Melanoma Diagnosis, Outcomes and Survival," and "Advanced Conditions."
Latest:
Reflecting on the Growth of NPs and PAs in DermatologyAt the inaugural Horizons in Advanced Practice meeting, Lakshi Aldredge, MSN, ANP-BC, reviewed complex cases on AD and PsO and the role of PAs and NPs in advancing patient care.
Latest:
Dermatology NP Practice is Evolving as Demand IncreasesThere are more than 355,000 nurse practitioners licensed in the United States in a variety of practice areas.
Latest:
Vitiligo Linked to Insomnia RiskA new study showed about half of all vitiligo patients from a care system were burdened with the sleeping disorder.
Latest:
Late-Breaking Data: Super Responders With Delgocitinib for CHEApril Armstrong, MD, MPH, FAAD, discusses her late-breaking presentation at AAD on the treatment response in patients with moderate to severe chronic CHE treated with delgocitinib.
Latest:
A 7-Year-Old Girl With a Recent PsO DiagnosisMichael Lewitt, MD, discusses a case involving a 7-year-old girl with plaque psoriasis (PsO) affecting body surface area (BSA) and the face, emphasizing the limited pediatric treatment options and the psychological and social impact on the child; the family initially opted for topical treatments like roflumilast, but preferred a more proactive approach, transitioning to apremilast while addressing concerns about gastrointestinal adverse events and the patient’s aversion to needles.
Latest:
Shin Guard Dermatitis: What's the Diagnosis?A new allergen, acetophenone azine with generalized autoeczematization, is the cause of “shin guard dermatitis.”
Latest:
Cosmetic procedure complications in darker skinSome adverse reactions to cosmetic procedures occur more often in patients with darker skin types. Patients should be counseled on appropriate cosmetic procedures for their skin type, according to Cheryl M. Burgess, M.D., at the Skin of Color Update virtual meeting.
Latest:
Vitiligo, Melasma, PIH, and Albinism: Clinical Update and Emerging TherapiesReview emerging therapies for vitiligo, melasma, PIH, and albinism, including topical, systemic, light-based, and laser treatments.
Latest:
Topical Steroid Withdrawal: Uncovering Neuroinflammatory MechanismsOur May cover story explores NIH’s new findings on topical steroid withdrawal, a condition now under scientific scrutiny as a distinct entity.
